Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2026 16:05 ET | Source: electroCore, Inc.

electroCore Announces First Quarter 2026 Financial Results

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year...
April 30, 2026 08:00 ET | Source: electroCore, Inc.

electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge

ROCKAWAY, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that TAC-STIM™, its non-invasive...
April 29, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial...
April 28, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in...
April 23, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced its participation in Hacking the...
April 08, 2026 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
April 07, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight...
April 01, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical...
March 31, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

ROCKAWAY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Seth Abrams...
March 30, 2026 08:00 ET | Source: electroCore, Inc.

electroCore Expands Intellectual Property Portfolio

ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S....